At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We received an updated WNV package insert; please note the manufacturer and license number has been ...